WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a global leader in life sciences solutions, today announced it has named Peter Hoenigsberg to its Board of Directors. Mr. Hoenigsberg’s CEO and private equity experience brings a valuable level of business knowledge and perspective to the Board.
Mr. Hoenigsberg most recently was a senior advisor for Providence Equity Partners helping build their information services portfolio. Prior to joining Providence, he was CEO of Decision Resources Group (DRG), a highly successful life sciences market research firm sold to the Piramal Group in June 2012. Before joining DRG, Mr. Hoenigsberg was an operating partner with the private equity firm Castanea Partners.
“We are pleased to welcome Peter as a new director to the Trinity Board,” said Dave Fitzhenry, CEO of Trinity. “His background and viewpoints will add to the already engaging discussions the Board has as we plan for continued growth and look to create a balanced mix of high-value offerings to our life science clients.”
Mr. Hoenigsberg was also a leader in the publishing industry for 25 years and has held various senior executive positions with the Thomson Corporation, Harcourt, and Addison-Wesley/Pearson. He served as president and CEO of Harcourt’s largest and most profitable division, the Worldwide Scientific, Technical and Medical Group and served at the Thomson Corporation where he ran the International and Media Group for ITP.
About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.